Avience Biomedicals Ltd vs Indegene Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Avience Biomedicals Ltd is ₹ 240 as of 23 Oct 15:30 . The P/E Ratio of Avience Biomedicals Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe P/E Ratio of Indegene Ltd changed from 34 on March 2025 to 26 on March 2026 . This represents a CAGR of -12.55% over 2 years The Market Cap of Avience Biomedicals Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Market Cap of Indegene Ltd changed from ₹ 13878 crore on March 2025 to ₹ 10469 crore on March 2026 . This represents a CAGR of -13.14% over 2 years The revenue of Avience Biomedicals Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Indegene Ltd for the Jun '26 is ₹ 1092 crore as compare to the Mar '26 revenue of ₹ 1014 crore. This represent the growth of 7.68% The ebitda of Avience Biomedicals Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Indegene Ltd for the Jun '26 is ₹ 203.2 crore as compare to the Mar '26 ebitda of ₹ 154.1 crore. This represent the growth of 31.86% The net profit of Avience Biomedicals Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The net profit of Indegene Ltd changed from ₹ 87.7 crore to ₹ 116.2 crore over 9 quarters. This represents a CAGR of 13.32% The Dividend Payout of Avience Biomedicals Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Indegene Ltd changed from 26.42 % on March 2025 to 25.54 % on March 2026 . This represents a CAGR of -1.68% over 2 years .

About Avience Biomedicals Ltd

Avience Biomedicals Limited was originally incorporated as Private Limited Company as 'Avience Biomedicals Private Limited' on December 23, 2019 with the Registrar of Companies, Delhi.
Later, Company's status got converted into a Public Limited Company, the name of the Company was changed to 'Avience Biomedicals Limited' and fresh Certificate of incorporation dated September 3, 2024, was issued by the Registrar of Companies, Delhi. Avience Biomedicals Limited is a medical consumable company dedicated to manufacturing of Vitro-Diagnostic (IVD) products and medical devices in Noida, Uttar Pradesh, India.
In vitro diagnostics (IVDs) are tests that can detect disease, conditions and infections. The Company commenced its journey by producing essential diagnostic kits like Viral Transport Media (VTM), Covid, Human Immunodeficiency Viruses (HIV), HBs AG, Malaria, Dengue and others aimed at aiding medical institutions with affordable and good-quality solutions.

About Indegene Ltd

Indegene Limited was incorporated as Indegene Lifesystems Private Limited' at Ahmedabad, Gujarat, as a Private Limited Company, dated October 16, 1998 at Ahmedabad.
Subsequently, name of the Company was changed to Indegene Private Limited' and a fresh Certificate of Incorporation was issued by the Registrar of Companies, Maharashtra at Mumbai on May 26, 2016.
Thereafter, Company converted to a Public Company with change in name to Indegene Limited' on November 17, 2022. The Company is a digital-first life sciences commercialization company, enabling biopharmaceutical, emerging biotech, and medical device companies to develop, launch, and scale the impact of their products with greater speed, precision, and efficiency.
As a specialized company, it combine healthcare domain expertise, fit-for-purpose technology, and an agile operating model to solve the most complex problems in the healthcare industry.

FAQs for the comparison of Avience Biomedicals Ltd and Indegene Ltd

Which company has a larger market capitalization, Avience Biomedicals Ltd or Indegene Ltd?

Market cap of Avience Biomedicals Ltd is 131 Cr while Market cap of Indegene Ltd is 13,768 Cr

What are the key factors driving the stock performance of Avience Biomedicals Ltd and Indegene Ltd?

The stock performance of Avience Biomedicals Ltd and Indegene Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Avience Biomedicals Ltd and Indegene Ltd?

As of October 25, 2026, the Avience Biomedicals Ltd stock price is INR ₹240.0. On the other hand, Indegene Ltd stock price is INR ₹571.5.

How do dividend payouts of Avience Biomedicals Ltd and Indegene Ltd compare?

To compare the dividend payouts of Avience Biomedicals Ltd and Indegene Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.